Pattern Recognition and Anomaly Detection in Fetal Morphology Using Deep Learning and Statistical Learning

Last updated: September 11, 2023
Sponsor: University of Craiova
Overall Status: Active - Recruiting

Phase

N/A

Condition

Holoprosencephaly

Birth Defects

Treatment

Ultrasound

Clinical Study ID

NCT05738954
PARADISE
  • Ages 18-50
  • Female
  • Accepts Healthy Volunteers

Study Summary

Congenital anomalies (CA) are the most encountered cause of fetal death, infant mortality and morbidity.7.9 million infants are born with CA yearly. Early detection of CA facilitates life-saving treatments and stops the progression of disabilities. CA can be diagnosed prenatally through Morphology Scan (MS). Discrepancies between pre and postnatal diagnosis of CA reach 29%. A correct interpretation of MS allows a detailed discussion regarding the prognosis with parents. The central feature of PARADISE is the development of a specialized intelligent system that embeds a committee of Deep Learning and Statistical Learning methods, which work together in a competitive/collaborative way to increase the performance of MS examinations by signaling CA. Using preclinical testing and clinical validation, the main goal will be the direct implementation into clinical practice. This multi-disciplinary project offers a unique integration of approaches, competences, breakthroughs in key applications in human, psychological, technological, and economical interest such as the 'smarter' healthcare system, opening new fields of research. PARADISE creates an environment that contributes significantly to the healthcare system, medical and pharma industries, scientific community, economy and ultimately to each individual. Its outcome will increase impact on the management of CA by enabling the establishment of detailed plans before birth, which will decrease morbidity and mortality in infants.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Second trimester pregnant women

Exclusion

Exclusion Criteria:

Study Design

Total Participants: 4000
Treatment Group(s): 1
Primary Treatment: Ultrasound
Phase:
Study Start date:
May 04, 2022
Estimated Completion Date:
December 31, 2024

Study Description

Probe guidance: The IS guides the sonographer's probe for better acquisition of the fetal biometric plane - Basic scanning to be performed by non-expert(> 90% accuracy (AC)) Fetal biometric plane finder: The fetal planes are automatically detected, measured and stored - Insurance that all anatomical parts are checked (100% AC) Anomaly detection: unusual findings are signaled - Assistance in decision making (>90% AC)

Connect with a study center

  • University Emergency County Hospital

    Craiova, Dolj 200643
    Romania

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.